These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 21176719)

  • 1. The pharmacokinetics and safety of desvenlafaxine in subjects with chronic renal impairment.
    Nichols AI; Richards LS; Behrle JA; Posener JA; McGrory SB; Paul J
    Int J Clin Pharmacol Ther; 2011 Jan; 49(1):3-13. PubMed ID: 21176719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Desvenlafaxine: a new serotonin-norepinephrine reuptake inhibitor for the treatment of adults with major depressive disorder.
    Perry R; Cassagnol M
    Clin Ther; 2009 Jun; 31 Pt 1():1374-404. PubMed ID: 19698900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An open-label, single-dose, parallel-group study of the effects of chronic hepatic impairment on the safety and pharmacokinetics of desvenlafaxine.
    Baird-Bellaire S; Behrle JA; Parker VD; Patat A; Paul J; Nichols AI
    Clin Ther; 2013 Jun; 35(6):782-94. PubMed ID: 23623756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of renal disease on the disposition of venlafaxine.
    Troy SM; Schultz RW; Parker VD; Chiang ST; Blum RA
    Clin Pharmacol Ther; 1994 Jul; 56(1):14-21. PubMed ID: 8033490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical utility of desvenlafaxine 50 mg/d for treating MDD: a review of two randomized placebo-controlled trials for the practicing physician.
    Reddy S; Kane C; Pitrosky B; Musgnung J; Ninan PT; Guico-Pabia CJ
    Curr Med Res Opin; 2010 Jan; 26(1):139-50. PubMed ID: 19919295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Desvenlafaxine succinate: a newer antidepressant for the treatment of depression and somatic symptoms.
    Seo HJ; Sohi MS; Patkar AA; Masand PS; Pae CU
    Postgrad Med; 2010 Jan; 122(1):125-38. PubMed ID: 20107296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Desvenlafaxine succinate for major depressive disorder.
    Sproule BA; Hazra M; Pollock BG
    Drugs Today (Barc); 2008 Jul; 44(7):475-87. PubMed ID: 18806899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Venlafaxine in human breast milk and nursing infant plasma: determination of exposure.
    Newport DJ; Ritchie JC; Knight BT; Glover BA; Zach EB; Stowe ZN
    J Clin Psychiatry; 2009 Sep; 70(9):1304-10. PubMed ID: 19607765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An assessment of drug-drug interactions: the effect of desvenlafaxine and duloxetine on the pharmacokinetics of the CYP2D6 probe desipramine in healthy subjects.
    Patroneva A; Connolly SM; Fatato P; Pedersen R; Jiang Q; Paul J; Guico-Pabia C; Isler JA; Burczynski ME; Nichols AI
    Drug Metab Dispos; 2008 Dec; 36(12):2484-91. PubMed ID: 18809731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Desvenlafaxine, a serotonin-norepinephrine uptake inhibitor for major depressive disorder, neuropathic pain and the vasomotor symptoms associated with menopause.
    Pae CU; Park MH; Marks DM; Han C; Patkar AA; Masand PS
    Curr Opin Investig Drugs; 2009 Jan; 10(1):75-90. PubMed ID: 19127490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of desvenlafaxine on the pharmacokinetics of desipramine in healthy adults.
    Nichols AI; Abell M; Chen Y; Behrle JA; Frick G; Paul J
    Int Clin Psychopharmacol; 2013 Mar; 28(2):99-105. PubMed ID: 23221858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single-Dose Pharmacokinetics and Safety of Solriamfetol in Participants With Normal or Impaired Renal Function and With End-Stage Renal Disease Requiring Hemodialysis.
    Zomorodi K; Chen D; Lee L; Lasseter K; Marbury T
    J Clin Pharmacol; 2019 Aug; 59(8):1120-1129. PubMed ID: 30865315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An integrated analysis of the efficacy and safety of desvenlafaxine in the treatment of major depressive disorder.
    Carrasco JL; Kornstein SG; McIntyre RS; Fayyad R; Prieto R; Salas M; Mackell J; Boucher M
    Int Clin Psychopharmacol; 2016 May; 31(3):134-46. PubMed ID: 26895080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of venlafaxine and O-desmethylvenlafaxine in laboratory animals.
    Howell SR; Hicks DR; Scatina JA; Sisenwine SF
    Xenobiotica; 1994 Apr; 24(4):315-27. PubMed ID: 8059535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Desvenlafaxine for the treatment of major depressive disorder.
    Kornstein SG; McIntyre RS; Thase ME; Boucher M
    Expert Opin Pharmacother; 2014 Jul; 15(10):1449-63. PubMed ID: 24914479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Desvenlafaxine succinate for major depressive disorder: a critical review of the evidence.
    Kamath J; Handratta V
    Expert Rev Neurother; 2008 Dec; 8(12):1787-97. PubMed ID: 19086875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A pooled analysis of the efficacy of desvenlafaxine for the treatment of major depressive disorder in perimenopausal and postmenopausal women.
    Kornstein SG; Clayton AH; Bao W; Guico-Pabia CJ
    J Womens Health (Larchmt); 2015 Apr; 24(4):281-90. PubMed ID: 25860107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and tolerability of desvenlafaxine succinate treatment for menopausal vasomotor symptoms: a randomized controlled trial.
    Speroff L; Gass M; Constantine G; Olivier S;
    Obstet Gynecol; 2008 Jan; 111(1):77-87. PubMed ID: 18165395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the pharmacokinetics of venlafaxine extended release and desvenlafaxine in extensive and poor cytochrome P450 2D6 metabolizers.
    Preskorn S; Patroneva A; Silman H; Jiang Q; Isler JA; Burczynski ME; Ahmed S; Paul J; Nichols AI
    J Clin Psychopharmacol; 2009 Feb; 29(1):39-43. PubMed ID: 19142106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Desvenlafaxine succinate for the treatment of major depressive disorder.
    Lohoff FW; Rickels K
    Expert Opin Pharmacother; 2008 Aug; 9(12):2129-36. PubMed ID: 18671467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.